MedPath

Prevalence, severity and origin of lymphedema among women five years after treatment for breast cancer.

Conditions
PrevalentieLymfoedeemBorstkankerChronischPrevalenceLymphedema Breast cancerChronic
Registration Number
NL-OMON23930
Lead Sponsor
afdeling Heelkunde, Academisch ziekenhuis Maastricht
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
266
Inclusion Criteria

Wemon who visited the mammapoli” for the first time in the period from January 2001 till December 2002 and were diagnosed with breast cancer.

Exclusion Criteria

If the breast cancer reoccurs, the patient will be excluded from further research. If the patient is death, she will be exluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary end goal is to determine the presence of lymphedema among female patients five years after the treatment for breast cancer. The water replacement technique is used to measure the arm volume. When the difference between the two arms is bigger than 150ml or 200ml, lymphedema is diagnosed.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath